10-43200777-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145313.4(RASGEF1A):c.571G>A(p.Val191Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145313.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASGEF1A | NM_145313.4 | c.571G>A | p.Val191Ile | missense_variant | 5/13 | ENST00000395810.6 | NP_660356.2 | |
RASGEF1A | NM_001282862.2 | c.595G>A | p.Val199Ile | missense_variant | 5/13 | NP_001269791.1 | ||
RASGEF1A | XM_005271809.4 | c.331G>A | p.Val111Ile | missense_variant | 4/12 | XP_005271866.1 | ||
RASGEF1A | XM_011539500.3 | c.331G>A | p.Val111Ile | missense_variant | 4/12 | XP_011537802.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASGEF1A | ENST00000395810.6 | c.571G>A | p.Val191Ile | missense_variant | 5/13 | 1 | NM_145313.4 | ENSP00000379155 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250584Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135624
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461600Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 727122
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2021 | The c.571G>A (p.V191I) alteration is located in exon 4 (coding exon 4) of the RASGEF1A gene. This alteration results from a G to A substitution at nucleotide position 571, causing the valine (V) at amino acid position 191 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at